Karola Jering

Karola Jering practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Karola Jering's NPI, 1598183758, was assigned on April 3, 2014. Karola Jering graduated from Vanderbilt University School of Medicine in 2014. Karola Jering holds Massachusetts license 270341.

Karola Jering's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Karola Jering's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Karola Jering is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Karola Jering to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Karola Jering practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Karola Jering's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Karola Jering's licenses on file in 2 states: Massachusetts and Maryland.

CMS data shows 232 Medicare services from Karola Jering across 3 procedure codes in 2024, for 133 Medicare patients. Medicare paid $24,271 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 133 Medicare patients who saw Karola Jering in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have heart failure, and 75% have high blood pressure. 34% are also on Medicaid. Their average risk score is 3.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Karola Jering's median patient age at 70, with 44% women.

In 2024, Karola Jering wrote 771 Medicare Part D claims for 95 patients. 67% of them were for generic drugs. CMS names the drug for 639 of them, across 19 drugs with 11 or more claims each, at $314,783 in total drug cost. In 2023, CMS named 264 claims across 10 drugs.

Karola Jering accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Karola Jering as offering telehealth.

Dmand AI links 45 papers to Karola Jering, published from 2015 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Heart Failure, Stroke Volume and Myocardial Infarction. Karola Jering has published most often in Eur J Heart Fail. Karola Jering's most frequent co-authors are Scott David Solomon, MD, Marc A. Pfeffer, MD and Muthiah Vaduganathan, MD, MPH.

CMS Open Payments shows 14 general payments to Karola Jering from 2 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 83% of the total. Alnylam Pharmaceuticals Inc. paid the most, $14,277. It also lists 6 research payments totaling $7,275 in 2025.

Karola Jering graduated from Vanderbilt University School of Medicine in 2014.